Plasma protein binding kinetics of valproic acid over a broad dosage range: therapeutic implications

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Clinical Pharmacy and Therapeutics

• Publication date

  1993-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1365-2710.1993.tb00612.xPMID 8345004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of Intractable Childhood Epilepsy with High‐Dose Valproate

  1992cited by this paper
• In vivo determination of valproate binding constants during sole and multi-drug therapy.

  1990cited by this paper
• In Vivo Determination of Valproate Binding Constants During Sole and Multi‐Drug Therapy

  1990cited by this paper
• Variations in protein binding of drugs in plasma and serum.

  1989cited by this paper
• Problems in therapeutic drug monitoring: free drug level monitoring.

  1988cited by this paper
• Clinical Pharmacokinetics of Valproic Acid — 1988

  1988cited by this paper
• NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models.

  1986cited by this paper
• Variable Free and Total Valproic Acid Concentrations in Sole- and Multi‐Drug Therapy

  1986cited by this paper
• NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models.

  1986cited by this paper
• An analysis program MULTI(ELS) based on extended nonlinear least squares method for microcomputers.

  1986cited by this paper
• An Update on Sodium Valproate

  1985cited by this paper
• Clinical Implications of Serum Protein Binding in Epileptic Children During Sodium Valproate Maintenance Therapy

  1984cited by this paper
• Pharmacokinetics of enteric-coated valproic acid.

  1984cited by this paper
• Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady state in epileptic patients.

  1983cited by this paper
• Valproic acid free fraction in epileptic children under chronic monotherapy.

  1983cited by this paper
• Interference of valproic acid in the colorimetric determination of free fatty acids in plasma.

  1982cited by this paper
• Sodium Valproate: Monotherapy and Polytherapy

  1982cited by this paper
• Intra-dose variation in plasma protein binding of sodium valproate in epileptic patients.

  1982cited by this paper
• Monitoring of free valproic acid levels?

  1980cited by this paper
• Valproic acid dosage and plasma protein binding and clearance

  1980cited by this paper
• Valproic Acid Binding to Human Serum Albumin and Determination of Free Fraction in the Presence of Anticonvulsants and Free Fatty Acids

  1979cited by this paper
• Sodium Valproate, Serum Level and Clinical Effect in Epilepsy: A Controlled Study

  1979cited by this paper
• Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease.

  1978cited by this paper
• Pharmacokinetic studies with valproic acid in man.

  1977cited by this paper
• Depression of drug metabolism in liver microsomes after treating rats with unsaturated fatty acids.

  1976cited by this paper
• The effects of unsaturated fatty acids on hepatic microsomal drug metabolism and cytochrome P-450.

  1969cited by this paper

• Incorporating measurement uncertainty into free valproic acid monitoring: estimation and clinical impact for therapeutic drug monitoring.

  2025cites this paper
• Predictors of valproic acid steady-state serum levels in adult and pediatric psychiatric inpatients: a comparative analysis

  2024cites this paper
• Derivation and Validation of a New Equation for Estimating Free Valproate Concentration in Critically Ill Adult Patients

  2023cites this paper
• A Novel Piezoresistive Microcantilever Structure for Free Valproic Acid Sensing in Personalized Epilepsy Management

  2023cites this paper
• A novel method for predicting the unbound valproic acid concentration.

  2023cites this paper
• Therapeutic drug monitoring of phenytoin and valproic acid in critically ill patients at Windhoek Central Hospital, Namibia

  2022cites this paper
• Clinical Pharmacokinetic Monitoring of Free Valproic Acid Levels: A Systematic Review

  2022cites this paper
• Determination of Free Valproic Acid Concentration in 569 Clinical Samples by LC-MS/MS After Hollow Fiber Centrifugal Ultrafiltration Treatment

  2021cites this paper
• CYP2C9*3/*3 Gene Expression Affects the Total and Free Concentrations of Valproic Acid in Pediatric Patients with Epilepsy

  2021cites this paper
• Switching Between LC-ESI-MS/MS and EMIT Methods for Routine TDM of Valproic Acid in Pediatric Patients With Epilepsy: What Clinicians and Researchers Need to Know

  2021cites this paper
• The Effect of Sample Handling on Free Valproic Acid Levels.

  2020cites this paper
• Determinants of free serum valproate concentration: A prospective study in patients on divalproex sodium monotherapy.

  2018cites this paper
• Appropriateness of Antiepileptic Drug-Level Monitoring at A Childrens’ Hospital in Mexico.

  2017cites this paper
• Individualizing Antiepileptic Therapy for Patients

  2017cites this paper
• Free and total p-cresol sulfate levels and infectious hospitalizations in hemodialysis patients in CHOICE and HEMO

  2017cites this paper
• UGT1A6- and UGT2B7-related valproic acid pharmacogenomics according to age groups and total drug concentration levels.

  2016cites this paper
• Direct Determination of a Small-Molecule Drug, Valproic Acid, by an Electrically-Detected Microcantilever Biosensor for Personalized Diagnostics

  2015cites this paper
• Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.

  2013cites this paper
• Repeated adverse hematologic reactions associated with valproic acid use in a patient with acquired renal insufficiency.

  2013cites this paper
• Predictability of individualized dosage regimens of carbamazepine and valproate mono‐ and combination therapy

  2011cites this paper
• The Impact of Dosage of Sustained-Release Formulation on Valproate Clearance and Plasma Concentration in Psychiatric Patients: Analysis Based on Routine Therapeutic Drug Monitoring Data

  2011cites this paper
• Hematological Effects of Valproate in Psychiatric Patients: What Are the Risk Factors?

  2010cites this paper
• [Not Available].

  2010cites this paper
• [Therapeutic drug monitoring of valproate].

  2010cites this paper
• Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model

  2009cites this paper
• Once-daily dosing is appropriate for extended-release divalproex over a wide dose range, but not for enteric-coated, delayed-release divalproex: evidence via computer simulations and implications for epilepsy therapy.

  2009cites this paper
• Evaluation of human plasma protein binding of trabectedin (Yondelis, ET-743).

  2009cites this paper
• Non-convulsive status epilepticus in adults : an overview

  2008cites this paper
• Pharmacokinetic considerations in clinical toxicology: clinical applications.

  2007cites this paper
• Pharmacokinetic Considerations in Clinical Toxicology

  2007cites this paper
• Measuring unbound versus total valproate concentrations for therapeutic drug monitoring.

  2006cites this paper
• Therapeutic Monitoring of Valproate in Psychiatry: How Far Have We Progressed?

  2006influential citation
• The neuropharmacokinetics of valproate in pentylenetetrazol-kindled conscious epileptic rat hippocampus

  2004cites this paper
• Drugs pharmacokinetics in ICU patients: consequences of hypoalbuminemia upon drugs monitoring and dosing scheme

  2004cites this paper
• Dose-Related Pharmacokinetics and Pharmacodynamics of Valproate in the Elderly

  2003cites this paper
• Appropriateness of serum level determinations of antiepileptic drugs.

  2003cites this paper
• Toxicity of free p-cresol: a prospective and cross-sectional analysis.

  2003cites this paper
• Dose-dependent pharmacokinetics and metabolism of valproic acid in newborn lambs and adult sheep.

  2001influential citation
• Assessment of Drug Concentrations in Tears in Therapeutic Drug Monitoring: I. Determination of Valproic Acid in Tears by Gas Chromatography/Mass Spectrometry With EC/NCI Mode

  2000cites this paper
• Absorption, distribution, and excretion

  1999cites this paper
• Valproic acid intoxication in a patient with bipolar disorder and chronic uremia.

  1999cites this paper
• Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate

  1998cites this paper
• Drug disposition in the maternal-fetal unit : studies with diphenhydramine and valproic acid in pregnant sheep

  1998cites this paper
• Pharmacokinetics, tissue distribution and serum protein binding of (E,Z)-2,3’-diene VPA in rats

  1996cites this paper
• Role of Newer Medications for Bipolar Disorder

  1996cites this paper
• Relation of serum valproate concentration to response in mania.

  1996cites this paper
• Multiple-Dose Evaluation of the Absorption Characteristics of Divalproex Sodium Tablets, a Delayed-Release Preparation of Valproate, in Healthy Volunteers

  1995cites this paper